EXPAREL (bupivacaine liposome injectable suspension), 1.3%, 266 mg/20 mL (13.3 mg/mL) single use vials, INVESTIGATIONAL USE. For Infiltration Only. Not for any other route of administration. Manufactured by Paelra Pharmaceuticals. Inc., San Diego, California, USA
Published March 6, 2013 · Recall initiated: December 17, 2012
Summary
FDA records drug Class II recall D-168-2013, published March 6, 2013 and initiated December 17, 2012. Recalling firm: Pacira Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 324 vials; Lot: Lot #11-2005 Control #23542 Manufacture Date: 05Dec11 2011-L-009. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Subpotent; bupivacaine
What to do
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Pacira Pharmaceuticals, Inc.
- Distributor
- Nationwide distribution: AZ, DC, FL, GA, MA, NJ, NY, OH, and TX.
- Lot
- Lot #11-2005 Control #23542 Manufacture Date: 05Dec11 2011-L-009
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAEXPAREL, Bupivicaine Liposome Injectable Suspension, 1.3%, 266 mg/20 mL (13 mg/mL), Sterile, 20 mL vial, RxDecember 11, 2019
- FDAFurosemide Injection USP (10 mg/mL), 4 mL in 5 mL Fliptop Vial, Rx only, Hospira Inc., Lake Forest, IL --- NDCMarch 6, 2013
- FDABelladonna Alkaloids (hyoscyamine sulfate, USP 0.1037 mg; atropine sulfate, USP 0.0194 mg; scopolamine HBr,March 6, 2013
- FDALiko Overhead Rail System, Ceiling Mounted Rail Systems for all Liko Stationary Lifts including Likorall,February 27, 2013
- FDAPhilips HeartStart XL+ Defibrillator/Monitor Model number: 861290 The HeartStart XL+ is intended for use in aFebruary 27, 2013
- FDAMEDRAD Hand Controller Sheath, Catalog number AVA 500 HCS/3010903, for cardiac catheterization procedures. TheFebruary 27, 2013
Questions about this recall
Was EXPAREL (bupivacaine liposome injectable suspension), 1.3%, 266 mg/20 mL (13.3 mg/mL) single use vials, INVESTIGATIONAL USE. For Infiltration Only. Not for any other route of administration. Manufactured by Paelra Pharmaceuticals. Inc., San Diego, California, USA recalled?
Yes. FDA published recall D-168-2013 on March 6, 2013. Reported hazard: Subpotent; bupivacaine
What should I do if I have this product?
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit